Variation in genes encoding the β 2 -adrenergic receptor (ADRB2) and angiotensin-converting enzyme (ACE) may influenceQ (cardiac output). The 46G > A (G16R) SNP (single nucleotide polymorphism) has been associated with β 2 -mediated vasodilation, but the effect of ADRB2 haplotypes onQ has not been studied. Five SNPs within ADRB2 (46G > A, 79C > G, 491C > T, 523C > A and 1053G > C by a pairwise tagging principle) and the I/D (insertion/ deletion) polymorphism in ACE were genotyped in 143 subjects. Cardiovascular variables were evaluated by the Model flow method at rest and during incremental cycling exercise. Only the G16R polymorphism was associated withQ . In carriers of the Arg 16 allele,Q rest (restingQ ) was 0.4 [95 % CI (confidence interval), 0.0-0.7] l/min lower than in G16G homozygotes (P = 0.048). During exercise, the increase inQ was by 4.7 (95 % CI, 4.3-5.2) l/min per litre increase in pulmonaryVo 2 (oxygen uptake) in G16G subjects, but the increase was 0.5 (0.0-0.9) l/min lower in Arg 16 carriers (P = 0.035). A similar effect size was observed for the Arg 16 haplotypes ACCCG and ACCCC. No interaction was found between ADRB2 and ACE polymorphisms. During exercise, the increase inQ was 0.5 (CI, 0.0 -1.0) l/min greater in ACE I/I carriers compared with I/D and D/D subjects (P = 0.054). In conclusion, the ADRB2 Arg 16 allele in humans is associated with a lowerQ both at rest and during exercise, overriding the effects of haplotypes.
INTRODUCTION
The β 2 -AR (β 2 -adrenergic receptor), encoded by an intronless gene (ADRB2) located on chromosome 5 (5q31-32), encompasses several SNPs (single nucleotide polymorphisms) [1] [2] [3] [4] that appear relevant to cardiovascular regulation at rest and during exercise and implicates progression of CVD (cardiovascular disease). In the coding region of ADRB2, four SNPs are non-synonymous polymorphisms resulting in amino acid variations G16R, Q27E, V34M and T164I. The polymorphism at codon 34 is rare and with no apparent functional consequence [5] . In contrast, in vitro studies indicate that polymorphisms at codons 16 and 27 affect agonist-induced down-regulation of the receptor and that polymorphisms at codon 164 alter the coupling properties to the intracellular G α s-protein [1, 2, 4] . The
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rare Ile 164 allele is associated with rapid progression of heart failure [6] .
The G16R and Q27E polymorphisms by themselves or in combination segregate with hypertension, asthma and obesity [1, 2, 4, 7] . In addition, homozygote Gly 16 subjects demonstrate a largerQ (cardiac output) both at rest and during exercise compared with homozygote Arg 16 subjects [8] , maybe because of a higher receptor density [9] . The Arg 16 allele is associated with enhanced agonist-mediated desensitization [10] and attenuated blood flow during infusion of a β-agonist in the brachial artery [11] . In contrast, the Glu 27 allele is associated with increased agonist-mediated responsiveness [10] . The role of haplotypes within ADRB2 is, however, not known, but it may be that the Gly 16 and Glu 27 haplotype promotes a more favourable cardiovascular response to exercise [3] .
Polymorphism in the ACE (angiotensin-converting enzyme) gene may also affect cardiovascular regulation during exercise. At intron 16 ACE is characterized by the presence (insertion, I allele) or absence (deletion, D allele) of a 287-bp Alu repeat sequence [12] . ACE degrades vasodilating kinins and generates AngII (angiotensin II). The I/D polymorphism is a consistent marker for ACE activity in Caucasians [13] . The I/D polymorphism explains approximately one-third of the variability in plasma ACE, with circulating levels being higher in D/D carriers than in subjects with the I/I genotype [13] . The ACE I/I genotype is reported to be over-represented in elite athletes and the I allele has been linked with endurance performance [14] [15] [16] , suggesting that the ACE I/D polymorphism may influenceQ during exercise.
Compared with a study of individual SNPs, involvement of haplotypes better reveals biological effects caused by the interaction of multiple polymorphisms [17] . In the present study, we used a pairwise tagging principle to select five marker SNPs within ADRB2 (G16R, Q27E, T164I, R175R and G351G) for construction of ADRB2 haplotypes [18] . By this approach we tested whether common human ADRB2 genotypes and haplotypes as well as the ACE I/D polymorphism by itself or by interaction with ADRB2 are associated withQ at rest and during cycling exercise.
MATERIALS AND METHODS

Subjects
At total of 143 subjects were included in the study following written informed consent as approved by the local ethical committee (J.nr. H-4-2010-027) and the Danish Data Protection Agency (J.nr. 2011-41-6600).
Subjects were studied after an overnight fast. Strenuous exercise was not allowed 24 h prior to the study and the subjects refrained from caffeine intake on the day of the experiment. Cardiovascular variables were measured at rest (n = 143), during submaximal exercise (n = 69) and at maximal exercise (n = 87). The subjects rested supine for 15 min after which HR (heart rate), MAP (mean arterial pressure), cardiac SV (stroke volume), and thusQ were assessed non-invasively as an average over 30 s using Modelflow methodology (Nexfin; BMEYE). Subjects hereafter exercised on a cycle ergometer (Model EC04; ePower Technology ApS) andVo 2 (oxygen uptake) was determined during submaximal and maximal exercise. Cycling exercise was performed on a custom-made eTenzor ® bike (ePower Technology ApS) securing that power was maintained irrespective of the self-chosen cadence, while ventilatory variables were determined breath-tobreath (Masterscreen CPX; VIASYS Healthcare). For evaluation at maximal exercise (n = 87), the initial workload was set at 75 W and then increased by 25 W/min until exhaustion while the subjects were encouraged to keep the pedalling rate. Subjects evaluated at submaximal exercise (n = 69) worked for -6 min at workloads of 75, 125 and 150-250 W, the last workload depending on the self-reported exhaustion level during the first two work periods (intensity level 1-10). The exercise periods were separated by 5 min of recovery with the subject sitting on the ergometer. Subjects choose a cadence of 60-105 rounds/min and kept that cadence for 1 min after initiating any given workload. After the submaximal exercise protocol, the subjects rested for 10-15 min while sitting on the ergometer before theV o 2max (maximumV o 2 ) test. Blood samples in EDTA vacuum tubes were obtained from an arm vein for determination of genotypes.
Selection of ADRB2 SNPs
The ADRB2 gene was located in HapMap (http://www.HapMap. org; HapMap DataRel 22/phase II Apr 07, on NCBI B36 assembly, dbSNP b126) and the SNP genotype data were analysed in Haploview 4.0 (http://www.HapMap.org). Five SNPs with a minor allele frequency > 1 % [46G > A (G16R), rs1042713; 79C > G (Q27E), rs1042714; 491C > T (T164I), rs1800888; 523C > A (R175R), rs1042718; and 1053G > C (G351G), rs1042719] were chosen to determine the most common haplotypes in Caucasians [18] [19] [20] .
Purification of DNA and genotyping DNA was purified from 200 μl of frozen whole-blood samples by the magnetic-bead-based MagneSil ® Blood Genomic, Max Yeld System (Promega). Genotyping was performed using TaqMan assays with the following rs and Applied Biosystems assay ID numbers: rs1042713, c___2084764_20; rs1042714, c___2084765_20; rs1800888, c___8950503_20; rs1042718, c___8950497_10; and rs1042719, c_8950496_10. The assays were analysed using PCR by a fast real-time PCR device (Applied Biosystem 7500) according to the manufacturer's instructions. Genotyping of the ACE I/D polymorphism was performed in duplicate using the primers 5 -CACACCCTGAAGTACGGCAC-3 (sense) and 5 -GTGGCCATCACATTCGTCAG-3 (antisense). As the D band is preferentially amplified with the initial primer set, resulting in some I/D genotypes being interpreted as D/D, we reanalysed the D/D genotypes with an I-specific primer [21, 22] .
Statistical analysis
Statistical analysis was with R version 2.13.2 (MAC GUI 1.42 Leopard build 64-bit, 5910; http://www.R-project.org). ANOVA was used for comparison of age, height, mass, BSA (body surface area) and BMI (body mass index) between genotypes, whereas Fisher's Exact test was used for gender. Haplotypes were estimated from genotypes using a Bayesian approach implemented with PHASE version 2.1; the programme estimates the haplotype frequencies in the sample population, the associated CI (confidence interval), and the most likely haplotype pair for each individual [23] . Genotype frequencies and Hardy-Weinberg equilibrium were calculated with software from the R-project (http://www.R-project.org). We initially used a haplotype score procedure ('haplo.stat') to estimate the relative strength of dominant, additive or recessive models onQ rest (restingQ) andQ in relation toV o 2 during exercise ( Q / V o 2 ). Then, genotype effects onQ rest were tested with linear models, whereas haplotype effects were evaluated by the use of the 'haplo.glm' procedure of the Haplo Stat package that allows for testing a genotype matrix with generalized linear models of dominant, additive or recessive haplotype effects [23] . 
Haplotype number Amino acid location . . .
V o 2 + a random error. ThusQ rest is the intercept, Q / V o 2 is the slope of the line, andQ increases linearly withV o 2 during submaximum exercise [24] . The Q / V o 2 relationship was tested under a mixed effects regression model ('nlme') with effects of the ADRB2 Arg 16 allele, BSA and age on both the intercept and slope (fixed effects). Subjects were included in the model as a random effect, i.e. that each subject has his/her own regression line with individual intercept and slope. Maximum likelihood generalized least-squares estimates were used throughout. Model assumptions were checked by examining residual plots, which in all cases were assessed to be close to normality. The method of covariate selection was to first include all biologically relevant confounders, i.e. sex, age and BSA, with two-way interactions and secondly proceed to the stepwise removal of effects with non-significant impact on the model fit. Cardiovascular and genetic data were analysed independently. Table 1 . Analysis of the five marker SNPs in ADRB2 revealed the existence of nine distinct haplotypes ( Table 2 ). The four most common haplotypes were observed in 94 % of the subjects, whereas the others each had frequencies below 3 % (Table 2 ). Genotype and haplotype distributions within ADRB2 and ACE were in close agreement with those observed in Caucasians [13, [18] [19] [20] 25, 26] . All genotypes and haplotypes were within Hardy-Weinberg equilibrium. There were no significant differences in sex, age, height, mass, BSA or BMI between genotypes, haplotypes or haplotype pairs. Haplotype scores for dominant, additive and recessive effects indicated a dominant effect on botḣ Q rest (P = 0.07) and Q / V o 2 (P = 0.047) that was associated with the ACCCG haplotype. All other haplotypes and models had lower scores that were not statistically significant. We therefore proceeded to test only dominant models.
Q at rest and ADRB2 polymorphisms Cardiovascular variables at rest and during incremental cycling are shown in Figure 1 . Only the G16R polymorphism was associated withQ at rest (Figure 2 ). Compared with R16R subjects,Q rest in G16G subjects was greater by 0.4 (CI, 0.0-0.7) l/min (P = 0.0482 adjusted for additive effects of age and BSA). Without adjustment for covariates, the effect was similar (difference = 0.4 l/min;, P = 0.029, Student's t test). None of the other SNPs were associated withQ or any other cardiovascular variables. Cardiovascular variables at rest in relation to ADRB2 G16R genotypes are shown in Table 3 . Highest values of HR and SV were observed in G16G subjects (Table 3 ), but none of the differences reached statistical significance. Influence of the four major haplotypes onQ rest is shown in Table 4 . The haplotypes ACCCG (#2) and ACCCC (#4) encompassing the Arg 16 allele had similar effect sizes as when the G16R polymorphism was Figure 1Q ,V o 2 , HR, SV, MAP and SVR at rest and during incremental cycling exercise at 75 W, 125, 200-300 W and at maximal workload Solid line denotes the median, the box the interquartile range and whiskers extend to the most extreme data point which is no more than the 1.5× interquartile range from the box.
tested alone, although not statistically significant when adjusted for age and BSA.
Q during incremental cycling and ADRB2 polymorphisms
The increase inQ during incremental exercise (n = 69) depended on age, BSA and the G16R polymorphism (Table 5 and Figure 2) . Carriers of G16G increased theirQ by 4.7 l/min (CI, 4.3 -5.2) for every 1 l/minV o 2 increase, whereas Arg 16 carriers of the same age and BSA had a Q of 4.2 l/min (CI, 3.8-4.7) ( Table 5 and Figure 2 ). In this model, the Arg 16 allele did not by itself exert a statistically significant effect on the intercept (Q rest ). During maximal exercise there were no difference inV o 2max or cardiovascular variables between genotypes. Throughout incremental exercise, highest values of MAP, HR and SV and lowest values of SVR (systemic vascular resistance) were observed in G16G subjects (results not shown), but none of the differences reached statistical significance.
The haplotype dominant model (Table 4 ) revealed a borderline significant effect of ACCCG (#2) on Q / V o 2 compared with the reference haplotype GGCCG (#1) (P = 0.056), with an estimated difference in Q / V o 2 of 0.5 (CI, 0.0-1.0) l/min. This effect is of the same magnitude as observed for the Arg 16 dominant genotype. As a difference in effects on Q / V o 2 between ACCCG and ACCCC may reflect a haplotype-specific effect separate from the G16R effect, we proceeded to analyse a subset of Table 4 ADRB2 gene haplotypes,Q rest and the relationship between changes inQ andV o 2 ( Q / V o 2 ) Estimated effects of a given haplotype onQ rest and Q / V o 2 during exercise with 95 % CI in parentheses for a 30-year-old subject with BSA of 1.9 m 2 . n = 143 forQ rest ; n = 69 for Q / V o 2 . P value (of t-statistic) of the difference from the haplotype GGCGG in a generalized linear model of haplotypes corrected for age and BSA. 
The mean (95 % CI) effect is given. n = 69. the data for subjects expressing either ACCCG or ACCCC and tested these differences against each other. ACCCG haplotypes (n = 32) had a Q / V o 2 of 0.3 (CI, 0.3-0.8) l/min lower than the ACCCC haplotypes (n = 12) (P = 0.33). Thus, the data do not support the presence of a haplotype-specific effect on Q / V o 2 . (Table 7 and Figure 2 ). Without adjustment for age and BSA this effect was significant (P = 0.025) and amounted to 0.7 ( − 0.1 to 1.1) l/min. Throughout incremental exercise, the highest values of MAP, HR and SV and lowest values of SVR were observed in I/I subjects (results not shown), but the differences did not reach statistical significance. During maximal exercise there were no difference inV o 2max or cardiovascular variables between ACE I/D genotypes. We evaluated bothQ rest and Q / V o 2 during exercise with the inclusion of interactive effects between ACE I/D and ADRB2 G16R; however, none were significant (P = 0.5 for interaction on Q / V o 2 and P = 0.21 for interaction onQ rest ). In subjects with the ADRB2 G16G genotype, the presence of the ACE I/I genotype (n = 14) did not increaseQ compared with the presence of the D/D genotype (n = 11; P = 0.26).
Model
ACE I/D polymorphism andQ
DISCUSSION
By the use of five marker SNPs in ADRB2, the present study in Scandinavian Caucasians identified four major haplotypes observed in 95 % of the subjects. The data indicate that only the G16R SNP in ADRB2 is associated withQ, independent of arrangements in haplotypes. The G16R SNP by itself produces higher values ofQ rest and Q / V o 2 in G16G homozygotes compared with G16R heterozygotes and R16R homozygotes. In addition, the study suggests that carriers of the ACE I/I genotype may have higher Q / V o 2 during incremental exercise than I/D and D/D subjects. The presence of the ACE I/I genotype, however, did not enhance the effect of the ADRB2 G16G genotype.
The results of the present study are in line with studies that have evaluated the effect of the G16R SNP on the cardiovascular response to exercise. In response to isometric handgrip, individuals homozygous for Gly 16 showed a greater increase in HR anḋ Q compared with subjects homozygous for Arg 16 [27] . Homozygote Gly 16 subjects demonstrated an increased cardiac SV anḋ Q both at rest and during exercise compared with homozygote Arg 16 subjects [8] . In addition, Gly 16 homozygotes had a greater fractional shortening, ejection fraction and midwall shortening compared with both heterozygotes and Arg 16 homozygotes [28] . In the present study, the G16G homozygotes had a higherQ rest compared with G16R heterozygotes and R16R homozygotes, but the difference inQ was smaller than reported by Snyder et al. [8] . The group of subjects in the two studies differs in that our group had a lower BMI and higherV o 2max . Furthermore, the age range was wider in our group of participants. There were also differences in methods of measuringQ. Snyder et al. [8] used the open-circuit acetylene uptake method, whereas we used the Modelflow method [29] . The Modelflow method seems to underestimate the increase inQ during heat stress [30] , but it has been successfully validated against a thermodilution estimate during a deliberate reduction in central blood volume induced by standing up in healthy subjects [31] , during cardiac surgery [32] , in intensive care medicine [33] and during liver transplantation surgery [34] .
Other SNPs in ADRB2 possess a potential effect on cardiovascular regulation. The Q27E SNP has been linked with increased agonist-mediated responsiveness [10] . Subjects homozygous for Gly 16 and Glu 27 demonstrated a greater forearm vasodilator response to mental stress and isometric handgrip, an effect that was attributed to position 27, since Gly 16 + Glu 27 subjects had a greater response than Gly 16 + Gln 27 and Arg 16 + Gln 27 subjects [35] . Snyder et al. [8] found that subjects homozygote for Gly 16 had a largerQ than Arg 16 homozygotes, but among G16G subjectsQ differed significantly according to the Q27E genotype, with Glu 27 homozygotes having the lowestQ. According to Snyder et al. [3] the primary difference in phenotype seems to be weighted by amino acids 16 and 27 (G16R and Q27E). In another study, the Gly 16 and Glu 27 haplotype combination has been suggested as a marker for talent identification of athletes [36] . We included haplotypes in our analysis, but did not find any significant effect of the combination of G16R and Q27E. Rather our data suggest that the G16R SNP alone seems to be responsible for the effect onQ both at rest and during exercise.
The ACE I/I genotype has been observed to be overrepresented in elite athletes and a positive association of the I allele with elite endurance performance has been suggested [16] . The genotypic effects on physiological phenotypes may be mediated by variation in the levels of ACE activity associated with the ACE I/D polymorphism [37] . Montgomery et al. [15] found LV (left ventricular) mass associated with the ACE D allele. In addition, the ACE D/D genotype has been linked with a small V o 2max [38, 39] . However, other studies found no such relationship [40, 41] . The results of the present study suggest that the ACE I/D polymorphism has no effect onQ rest , but during exercise the I/I genotype subjects had increasedQ/V o 2 compared with I/D and D/D subjects. Although this may support a beneficial effect of the I allele in promoting athletic performance, there was no difference inV o 2max between the ACE I/D genotypes. Moreover, we show that the presence of the ACE I/I genotype does not enhance the effect of the ADRB2 Gly/Gly genotype.
The present study has several limitations. First, the sample size was small, especially when the population was divided into subgroups, and the level of significance appeared to be borderline. The present study did not have enough statistical power to distinguish between the effect of the ADRB2 G16R polymorphism on HR and SV, and only the overall effect onQ was recognized. Secondly, circulating levels of catecholamines were not measured and it is possible that differences in receptor agonist concentrations influenced the results. The exact molecular mechanism of variation in ADRB2 remains unknown but may include unique interaction between genotypes in conformation and downstream signalling of β 2 -AR [2, 4] .
In conclusion, the results of the present study confirm that the ADRB2 G16R polymorphism is associated with a higherQ rest in G16G homozygotes compared with G16R heterozygotes and R16R homozygotes. Furthermore, during light-to-moderate exercise, G16G carriers demonstrate an enhanced increase inQ for a given increase inV o 2 compared with Arg 16 homozygotes. Analysis of ADRB2 haplotypes indicates that only the G16R SNP has such an effect, overriding the impact of haplotypes. The ACE I/I genotype may also augment the exercise-induced increase iṅ Q but does not interact with the effect of the ADRB2 G16R polymorphism.
CLINICAL PERSPECTIVES
r Endurance performance is highly dependent upon adequate increases inQ and oxygen delivery. In part, inter-individual differences in cardiovascular responses to exercise may be caused by genetic variation in ADRB2.
r We found that the G16R polymorphism in ADRB2 by itself, independent of arrangements in haplotypes, contributes to heterogeneity inQ at rest and during incremental exercise, along with age and body surface area.
r The results add to the understanding of gene-exercise interactions and genetic influence on sports performance.
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